31 million doses of Pfizer vaccine to arrive in Vietnam in Q3, 4
Vials containing the Pfizer Covid-19 vaccine. U.S. drugmaker Pfizer will provide Vietnam with 31 million doses of its Covid-19 vaccine in the third and fourth quarters of 2021 – PHOTO: MOH
HCMC – U.S. drugmaker Pfizer will provide Vietnam with 31 million doses of its Covid-19 vaccine in the third and fourth quarters of 2021, according to the Ministry of Health.
Truong Quoc Cuong, Deputy Minister of Health, told VnExpress on May 18 that the ministry signed a deal with Pfizer to buy its vaccine. The drugmaker pledged to sell the drugs to Vietnam at the lowest price as maintained for low-income nations. However, the price remained unrevealed.
To clinch the deal, the Ministry of Health had constantly been entering into negotiations on payments, risks, reimbursement and legal responsibilities with the U.S. drugmaker.
Besides the purchase of the Pfizer vaccine, the ministry is continuing to negotiate with other international drugmakers to buy the AstraZeneca, Moderna and Gamaleya vaccines. The ministry is also seeking to obtain a Covid-19 vaccine manufacturing technology transfer.
On May 17, at a meeting of the Government on the purchase of the Pfizer Covid-19 vaccine, Prime Minister Pham Minh Chinh said the procurement of Covid-19 vaccines is a necessary and urgent task. The Ministry of Health was told to take responsibility for the selection of the Covid-19 vaccines.
- Vietnam has recorded local Covid-19 cases in 40 cities and provinces
- In Photos Tam Thanh village painted with new colorful murals
- CAAV asks Transport Ministry for consultancy over cargo airline project
- Vietnam Covid 19 Updates June 15 245 new case 2 new deaths reported
- German friends awarded with Vietnam’s noble distinctions
CAAV asks Transport Ministry for consultancy over cargo airline project
Cyber Risk | It’s time to focus and take action!
Vietnam’s Phenikaa group invests US$1.5 million in local tech startup. Here’s the reason
It has never been easier for doing business in Vietnam as a foreigner?
Businesses struggle with rising costs during COVID-19